WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Actym Therapeutics, Inc.
United States
- Berkeley, CA
- 20/10/2023
- Series A
- $59,500,000
Actym Therapeutics is a cutting-edge biotech focused on the discovery and development of novel immuno-oncology therapies.
- Industry Biotechnology Research
- Website https://actymthera.com/
- LinkedIn https://www.linkedin.com/company/actym-therapeutics-inc/about/
Related People
Christopher ThanosCo Founder
United States -
Belvedere Tiburon, California
• Significant entrepreneurial and leadership experience in the biotechnology industry
• 30 years R&D experience
• Design, engineering, and production of cell therapies, ADC's, enzymes, and alternative scaffolds
• Comprehensive understanding of pipeline flow, from lead optimization to IND, to clinical POC
• Established skills in competitive intelligence, strategy, due diligence, portfolio management
• Inventor on multiple issued patents covering biotherapeutics
• First author publications in high impact factor journals such as Science, PNAS, JACS
• Effectively managed large teams
• Invited speaker, workshop leader, conference chair at several international meetings
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)